Related Experiment Video

Updated: May 28, 2025

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

5.9K

Exploring NK cell dynamics and the CD47-SIRPα axis in colon cancer

Latif Yilmaz1, Serdar Oztuzcu2, Omer Eronat3

  • 1Department of General Surgery Faculty of Medicine Gaziantep University Gaziantep Turkey.

Human Immunology
|February 11, 2025
PubMed

Insights

The SIRPα/CD47 immune checkpoint axis impacts colon cancer. Post-surgery, NK cell numbers decrease, while SIRPα levels on NK cells decline, suggesting a complex role in colorectal cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Immunotherapy

Background:

  • The SIRPα/CD47 axis is a key immune checkpoint, inhibiting phagocytosis of self-cells by macrophages.
  • Targeting this axis offers potential for cancer immunotherapy, particularly in colorectal cancer.
  • Understanding NK cell dynamics and CD47/SIRPα interactions is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate NK cell dynamics in colon cancer patients post-surgery.
  • To evaluate the impact of the CD47/SIRPα axis on NK cells in colorectal cancer.
  • To assess changes in SIRPα and CD47 expression in relation to NK cell activity and tumor characteristics.

Main Methods:

  • Analysis of NK cell numbers and Interferon-gamma (IFNγ) levels in colon cancer patients.
  • Assessment of CD47 immunoreactivity in tumor tissues.
  • Quantification of SIRPα expression on NK cells (CD16+/56+ and CD3-) post-surgery.

Main Results:

  • A significant, time-dependent decrease in NK cell counts was observed after surgery.
  • IFNγ levels were lower in patients than in healthy controls and did not change post-surgery.
  • Tumors showed low CD47 expression, and postoperative SIRPα levels on NK cells were significantly reduced in patients, irrespective of CD47 status.

Conclusions:

  • The CD47/SIRPα axis plays a complex role in colorectal cancer.
  • NK cell numbers decline post-surgery, indicating potential immune suppression.
  • Further research with larger cohorts is needed to confirm these findings and their therapeutic implications.
Keywords:
CD47Colon cancerIFNγNK cellsSIRPα

More Related Videos

In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

35.0K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.0K

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K